AGP Executive Report
Last update: 10 hours agoGenomics Dispute: The US barred imports from three Chinese biotech firms, including BGI, over alleged forced-labor links in Xinjiang. Beijing rejected the allegations, escalating tensions in biotech trade. Research and Innovation: Chinese cancer drugmakers drew attention at a global oncology congress, while China approved a brain implant designed to help people with paralysis use their hands. Healthcare Cooperation: Chinese and Swiss businesses discussed collaboration in biomedicine and AI; separately, a Chinese hospital ship provided care in Ghana. Health System Pressures: China’s old-age dependency ratio surpassed its child dependency ratio for the first time in 2025, sharpening the challenge of meeting older people’s care needs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.